{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:30:36Z","timestamp":1772793036557,"version":"3.50.1"},"reference-count":23,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.3892\/mco.2014.263","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T13:53:40Z","timestamp":1392904420000},"page":"375-379","source":"Crossref","is-referenced-by-count":5,"title":["Palonosetron exhibits higher total control rate compared to first-generation serotonin antagonists and improves appetite in delayed-phase chemotherapy-induced nausea and vomiting"],"prefix":"10.3892","volume":"2","author":[{"given":"HIROKI","family":"UEDA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHIGUSA","family":"SHIMONO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOMOYASU","family":"NISHIMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MEGUMI","family":"SHIMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROKI","family":"YAMAUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,2,20]]},"reference":[{"key":"key20180107150637_b1-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00520-005-0803-x","article-title":"Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials","volume":"13","author":"Neymark","year":"2005","journal-title":"Support Care Cancer"},{"key":"key20180107150637_b2-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1200\/JCO.2006.06.9591","article-title":"American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006","volume":"24","author":"American Society of Clinical Oncology","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180107150637_b3-mco-02-03-0375","unstructured":"National Comprehensive Cancer NetworkNCCN Practice Guidelines in OncologyAvailable at:www.nccn.org. Accessed August 10, 2013."},{"key":"key20180107150637_b4-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"v232","DOI":"10.1093\/annonc\/mdq194","article-title":"ESMO\/MASCC Guidelines Working Group: Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference","volume":"21","author":"Rolia","year":"2010","journal-title":"Ann Oncol"},{"key":"key20180107150637_b5-mco-02-03-0375","volume-title":"Guidelines for antiemetics in Oncology 2010","author":"Japan Society of Clinical Oncology","edition":"1st edition"},{"key":"key20180107150637_b6-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/00003495-199652050-00002","article-title":"Drug treatment of chemotherapy-induced delayed emesis","volume":"52","author":"Tavorath","year":"1996","journal-title":"Drugs"},{"key":"key20180107150637_b7-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra0706547","article-title":"Chemotherapy-induced nausea and vomiting","volume":"358","author":"Hesket","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180107150637_b8-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/1097-0142(20001201)89:11<2301::AID-CNCR19>3.0.CO;2-6","article-title":"Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials","volume":"89","author":"del Giglio","year":"2000","journal-title":"Cancer"},{"key":"key20180107150637_b9-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1200\/JCO.2005.04.022","article-title":"Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications","volume":"23","author":"Geling","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107150637_b10-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1200\/JCO.2005.09.050","article-title":"Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy","volume":"23","author":"Warr","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107150637_b11-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(08)70313-9","article-title":"Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial","volume":"10","author":"Saito","year":"2009","journal-title":"Lancet Oncol"},{"key":"key20180107150637_b12-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00002820-199708000-00005","article-title":"Similarities and differences in assessing nausea on a verbal category scale and a visual analogue scale","volume":"20","author":"B\u00f6rjeson","year":"1997","journal-title":"Cancer Nurs"},{"key":"key20180107150637_b13-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00265968","article-title":"Assessment of nausea","volume":"38","author":"Del Favero","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"key20180107150637_b14-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/annonc\/mdp195","article-title":"A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy","volume":"20","author":"Maemondo","year":"2009","journal-title":"Ann Oncol"},{"key":"key20180107150637_b15-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/cncr.11817","article-title":"Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist","volume":"98","author":"Eisenberg","year":"2003","journal-title":"Cancer"},{"key":"key20180107150637_b16-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.aat.2011.06.002","article-title":"Dexamethasone prevents postoperative nausea and vomiting: benefit versus risk","volume":"49","author":"Ho","year":"2011","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"key20180107150637_b17-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1200\/JCO.1998.16.9.2937","article-title":"Double-blind, dose-finding study of four intravenous doses of dexamethasone in the prevention of cisplatin-induced acute emesis. Italian Group for Antiemetic Research","volume":"16","author":"No authors listed","year":"1998","journal-title":"J Clin Oncol"},{"key":"key20180107150637_b18-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/annonc\/mdl347","article-title":"Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis","volume":"18","author":"Grunberg","year":"2007","journal-title":"Ann Oncol"},{"key":"key20180107150637_b19-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00520-004-0703-5","article-title":"Emesis induced by low or minimal emetic risk chemotherapy","volume":"13","author":"Tonato","year":"2005","journal-title":"Support Care Cancer"},{"key":"key20180107150637_b20-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199501053320101","article-title":"Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer","volume":"332","author":"Italian Group for Antiemetic Research","year":"1995","journal-title":"N Engl J Med"},{"key":"key20180107150637_b21-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/annonc\/mdj078","article-title":"Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia international antiemetic consensus conference","volume":"17","author":"Roila","year":"2006","journal-title":"Ann Oncol"},{"key":"key20180107150637_b22-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1756-9966-28-131","article-title":"Clinical research of olanzapine for prevention of chemotherapy-induced nausea and vomiting","volume":"23","author":"Tan","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107150637_b23-mco-02-03-0375","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1053\/j.gastro.2008.02.078","article-title":"Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism","volume":"134","author":"Takeda","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2014.263\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T15:17:31Z","timestamp":1597504651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2014.263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,20]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,2,20]]},"published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.3892\/mco.2014.263"],"URL":"https:\/\/doi.org\/10.3892\/mco.2014.263","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,20]]}}}